这是一篇来自已证抗体库的有关人类 CD59的综述,是根据38篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD59 抗体。
CD59 同义词: 16.3A5; 1F5; EJ16; EJ30; EL32; G344; HRF-20; HRF20; MAC-IP; MACIF; MEM43; MIC11; MIN1; MIN2; MIN3; MIRL; MSK21; p18-20; CD59 glycoprotein; 1F5 antigen; 20 kDa homologous restriction factor; CD59 antigen p18-20 (antigen identified by monoclonal antibodies 16.3A5, EJ16, EJ30, EL32 and G344); CD59 molecule, complement regulatory protein; Ly-6-like protein; MEM43 antigen; T cell-activating protein; human leukocyte antigen MIC11; lymphocytic antigen CD59/MEM43; membrane attack complex (MAC) inhibition factor; membrane attack complex inhibition factor; membrane inhibitor of reactive lysis; protectin; surface anitgen recognized by monoclonal antibody 16.3A5

赛默飞世尔
小鼠 单克隆(OV9A2)
  • 流式细胞仪; 人类; 图 6a
赛默飞世尔 CD59抗体(Miltenyi Biotec, 17-0596-42)被用于被用于流式细胞仪在人类样品上 (图 6a). Nat Commun (2017) ncbi
小鼠 单克隆(MEM-43)
  • 免疫印迹; 人类; 图 s2
赛默飞世尔 CD59抗体(Thermo Scientific, MEM-43)被用于被用于免疫印迹在人类样品上 (图 s2). Eur J Pharm Sci (2017) ncbi
小鼠 单克隆(MEM-43)
  • 免疫细胞化学; 猪; 1:100; 图 1b
  • 免疫印迹; 猪; 1:500; 图 s1f
赛默飞世尔 CD59抗体(Thermo Scientific, MA1-19133)被用于被用于免疫细胞化学在猪样品上浓度为1:100 (图 1b) 和 被用于免疫印迹在猪样品上浓度为1:500 (图 s1f). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(MEM-43)
  • 免疫细胞化学; 人类; 图 3
赛默飞世尔 CD59抗体(Thermo Fisher, MA1-82206)被用于被用于免疫细胞化学在人类样品上 (图 3). J Immunol (2016) ncbi
小鼠 单克隆(MEM-43)
  • 免疫沉淀; 人类; 图 3a
赛默飞世尔 CD59抗体(ThermoScientific, MEM-43)被用于被用于免疫沉淀在人类样品上 (图 3a). Cell Death Dis (2015) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类; 图 s4
  • 免疫细胞化学; 人类; 1:20
赛默飞世尔 CD59抗体(生活技术, MHCD5904)被用于被用于流式细胞仪在人类样品上 (图 s4) 和 被用于免疫细胞化学在人类样品上浓度为1:20. Stem Cells Transl Med (2015) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Invitrogen, MEM-43)被用于被用于流式细胞仪在人类样品上. Cytometry B Clin Cytom (2015) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Invitrogen, MEM-43)被用于被用于流式细胞仪在人类样品上. Hematology (2015) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(noco, MHCD5904)被用于被用于流式细胞仪在人类样品上. PLoS ONE (2013) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD59抗体(noco, MHCD5904)被用于被用于流式细胞仪在人类样品上 (图 3). Blood (2013) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 猕猴; 图 1
赛默飞世尔 CD59抗体(Invitrogen, MEM-43)被用于被用于流式细胞仪在猕猴样品上 (图 1). Cytometry A (2012) ncbi
小鼠 单克隆(MEM-43)
  • 免疫细胞化学; 人类
赛默飞世尔 CD59抗体(Invitrogen, MEM-43)被用于被用于免疫细胞化学在人类样品上. Transfusion (2011) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD59抗体(Invitrogen, MEM43)被用于被用于流式细胞仪在人类样品上 (图 2). Cytometry B Clin Cytom (2010) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类; 1:40
赛默飞世尔 CD59抗体(Caltag, noca)被用于被用于流式细胞仪在人类样品上浓度为1:40. Cytometry A (2009) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Invitrogen, Mem-43)被用于被用于流式细胞仪在人类样品上. J Exp Med (2008) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Caltag, MEM-43)被用于被用于流式细胞仪在人类样品上. J Immunol (2006) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Caltag, MEM-43)被用于被用于流式细胞仪在人类样品上. J Cell Physiol (2005) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Caltag, MEM-43)被用于被用于流式细胞仪在人类样品上. Am J Clin Pathol (2004) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Caltag, MEM43)被用于被用于流式细胞仪在人类样品上. J Hepatol (2004) ncbi
小鼠 单克隆(MEM-43)
  • 免疫组化; 人类
赛默飞世尔 CD59抗体(Caltag, MEM-43)被用于被用于免疫组化在人类样品上. J Am Acad Dermatol (2003) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Caltag, MEM-43)被用于被用于流式细胞仪在人类样品上. Br J Haematol (1998) ncbi
小鼠 单克隆(MEM-43)
  • 免疫沉淀; 人类; 图 1
赛默飞世尔 CD59抗体(Caltag, MEM-43)被用于被用于免疫沉淀在人类样品上 (图 1). Proc Natl Acad Sci U S A (1996) ncbi
小鼠 单克隆(MEM-43)
  • 免疫印迹; 人类; 图 4
赛默飞世尔 CD59抗体(Caltag Laboratories, clone MEM-43)被用于被用于免疫印迹在人类样品上 (图 4). J Neurochem (1996) ncbi
小鼠 单克隆(MEM-43)
  • 免疫沉淀; 人类
赛默飞世尔 CD59抗体(caltag, MEM-43)被用于被用于免疫沉淀在人类样品上. Am J Hematol (1995) ncbi
小鼠 单克隆(MEM-43)
  • 流式细胞仪; 人类
赛默飞世尔 CD59抗体(Zymed, MEM-43)被用于被用于流式细胞仪在人类样品上. Eur J Immunol (1990) ncbi
圣克鲁斯生物技术
小鼠 单克隆(H-7)
  • 免疫印迹; 小鼠; 图 2i
圣克鲁斯生物技术 CD59抗体(Santa Cruz Biotechnology Inc, sc-133170)被用于被用于免疫印迹在小鼠样品上 (图 2i). Cancer Res (2018) ncbi
小鼠 单克隆(B-3)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 CD59抗体(Santa Cruz, sc-133171)被用于被用于免疫印迹在人类样品上 (图 3). J Proteome Res (2017) ncbi
小鼠 单克隆(B-3)
  • 免疫组化-石蜡切片; 人类
圣克鲁斯生物技术 CD59抗体(Santa Cruz Biotechnology, sc-133171)被用于被用于免疫组化-石蜡切片在人类样品上. Arch Pathol Lab Med (2014) ncbi
大鼠 单克隆(YTH53.1)
  • 免疫印迹; 人类; 图 7b
圣克鲁斯生物技术 CD59抗体(Santa Cruz Biotechnology, YTH53.1)被用于被用于免疫印迹在人类样品上 (图 7b). Am J Physiol Gastrointest Liver Physiol (2014) ncbi
BioLegend
小鼠 单克隆(p282 (H19))
  • 抑制或激活实验; 小鼠; 图 s5i
BioLegend CD59抗体(Biolegend, p282/H19)被用于被用于抑制或激活实验在小鼠样品上 (图 s5i). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(p282 (H19))
  • 流式细胞仪; 人类
BioLegend CD59抗体(Biolegend, #304706)被用于被用于流式细胞仪在人类样品上. Am J Transplant (2015) ncbi
艾博抗(上海)贸易有限公司
兔 单克隆(EPR6425(2))
  • 免疫组化-石蜡切片; 人类; 图 s1
艾博抗(上海)贸易有限公司 CD59抗体(abcam, ab133707)被用于被用于免疫组化-石蜡切片在人类样品上 (图 s1). Sci Rep (2016) ncbi
伯乐(Bio-Rad)公司
小鼠 单克隆(MEM-43)
  • 免疫细胞化学; 人类
伯乐(Bio-Rad)公司 CD59抗体(AbD Serotec, MCA1054GA)被用于被用于免疫细胞化学在人类样品上. Cell Tissue Res (2014) ncbi
碧迪BD
小鼠 单克隆(p282)
  • 其他; 人类; 500 ug/ml; 图 1
碧迪BD CD59抗体(Becton Dickinson, 555761)被用于被用于其他在人类样品上浓度为500 ug/ml (图 1). J Extracell Vesicles (2016) ncbi
小鼠 单克隆(p282)
  • 流式细胞仪; 人类; 图 st1
碧迪BD CD59抗体(BD, 555764)被用于被用于流式细胞仪在人类样品上 (图 st1). Exp Cell Res (2016) ncbi
小鼠 单克隆(p282)
  • 流式细胞仪; 人类; 图 S5
碧迪BD CD59抗体(BD Biosciences, clone p282)被用于被用于流式细胞仪在人类样品上 (图 S5). Invest Ophthalmol Vis Sci (2014) ncbi
小鼠 单克隆(p282)
  • 流式细胞仪; 人类
碧迪BD CD59抗体(BD Pharmingen, p282/H19)被用于被用于流式细胞仪在人类样品上. J Biol Chem (2014) ncbi
Hycult Biotech
小鼠 单克隆(MEM-43)
  • 免疫组化-冰冻切片; 小鼠; 1:50; 表 3
  • 免疫组化-冰冻切片; 人类; 1:50; 表 3
Hycult Biotech CD59抗体(Hycult, HM2120)被用于被用于免疫组化-冰冻切片在小鼠样品上浓度为1:50 (表 3) 和 被用于免疫组化-冰冻切片在人类样品上浓度为1:50 (表 3). J Neuroinflammation (2016) ncbi
文章列表
  1. Wan Y, Wang L, Zhu C, Zheng Q, Wang G, Tong J, et al. Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery. Cancer Res. 2018;78:798-808 pubmed 出版商
  2. Huang N, Pishesha N, Mukherjee J, Zhang S, Deshycka R, Sudaryo V, et al. Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin. Nat Commun. 2017;8:423 pubmed 出版商
  3. Staubach S, Müller S, Pekmez M, Hanisch F. Classical Galactosemia: Insight into Molecular Pathomechanisms by Differential Membrane Proteomics of Fibroblasts under Galactose Stress. J Proteome Res. 2017;16:516-527 pubmed 出版商
  4. Puhka M, Nordberg M, Valkonen S, Rannikko A, Kallioniemi O, Siljander P, et al. KeepEX, a simple dilution protocol for improving extracellular vesicle yields from urine. Eur J Pharm Sci. 2017;98:30-39 pubmed 出版商
  5. Tan L, Toops K, Lakkaraju A. Protective responses to sublytic complement in the retinal pigment epithelium. Proc Natl Acad Sci U S A. 2016;113:8789-94 pubmed 出版商
  6. Clark A, Petty H. Identification of lesion subtypes in biopsies of ductal carcinoma in situ of the breast using biomarker ratio imaging microscopy. Sci Rep. 2016;6:27039 pubmed 出版商
  7. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed 出版商
  8. Bahia El Idrissi N, Bosch S, Ramaglia V, Aronica E, Baas F, Troost D. Complement activation at the motor end-plates in amyotrophic lateral sclerosis. J Neuroinflammation. 2016;13:72 pubmed 出版商
  9. Krampitz G, George B, Willingham S, Volkmer J, Weiskopf K, Jahchan N, et al. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors. Proc Natl Acad Sci U S A. 2016;113:4464-9 pubmed 出版商
  10. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed 出版商
  11. Sartain S, Turner N, Moake J. TNF Regulates Essential Alternative Complement Pathway Components and Impairs Activation of Protein C in Human Glomerular Endothelial Cells. J Immunol. 2016;196:832-45 pubmed 出版商
  12. LaRocca T, Stivison E, Mal Sarkar T, Hooven T, Hod E, Spitalnik S, et al. CD59 signaling and membrane pores drive Syk-dependent erythrocyte necroptosis. Cell Death Dis. 2015;6:e1773 pubmed 出版商
  13. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed 出版商
  14. Chou B, Gu H, Gao Y, Dowey S, Wang Y, Shi J, et al. A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach. Stem Cells Transl Med. 2015;4:320-32 pubmed 出版商
  15. Liew M, Farley M, Andreasen J, Parker C, Wittwer C. Rare event counting of CD59- red cells in human blood: A 47-month experience using PNH consensus guidelines for WBC and RBC testing in a reference lab. Cytometry B Clin Cytom. 2015;88:261-9 pubmed 出版商
  16. Shang Y, Chai N, Gu Y, Ding L, Yang Y, Zhou J, et al. Systematic immunohistochemical analysis of the expression of CD46, CD55, and CD59 in colon cancer. Arch Pathol Lab Med. 2014;138:910-9 pubmed 出版商
  17. Mrosewski I, Jork N, Gorte K, Conrad C, Wiegand E, Kohl B, et al. Regulation of osteoarthritis-associated key mediators by TNF? and IL-10: effects of IL-10 overexpression in human synovial fibroblasts and a synovial cell line. Cell Tissue Res. 2014;357:207-23 pubmed 出版商
  18. Wu Y, Wang Y, Qin F, Wang Z, Wang Y, Yang Y, et al. CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of ?-gal xenoantigen in colon tumor cells. Am J Physiol Gastrointest Liver Physiol. 2014;306:G1056-64 pubmed 出版商
  19. Yang P, Baciu P, Kerrigan B, Etheridge M, Sung E, Toimil B, et al. Retinal pigment epithelial cell death by the alternative complement cascade: role of membrane regulatory proteins, calcium, PKC, and oxidative stress. Invest Ophthalmol Vis Sci. 2014;55:3012-21 pubmed 出版商
  20. Sipol A, Babenko E, Borisov V, Naumova E, Boyakova E, Yakunin D, et al. An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort. Hematology. 2015;20:31-8 pubmed 出版商
  21. Du Y, Teng X, Wang N, Zhang X, Chen J, Ding P, et al. NF-?B and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack. J Biol Chem. 2014;289:2711-24 pubmed 出版商
  22. Rondelli T, Berardi M, Peruzzi B, Boni L, Caporale R, Dolara P, et al. The frequency of granulocytes with spontaneous somatic mutations: a wide distribution in a normal human population. PLoS ONE. 2013;8:e54046 pubmed 出版商
  23. Nevo Y, Ben Zeev B, Tabib A, Straussberg R, Anikster Y, Shorer Z, et al. CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood. 2013;121:129-35 pubmed 出版商
  24. Byrnes C, Terry Lee Y, Donahue R, Miller J. Identification of a cross-reacting, monoclonal anti-human CD233 antibody for identification and sorting of rhesus macaque erythrocytes. Cytometry A. 2012;81:165-8 pubmed 出版商
  25. Barcena A, Muench M, Kapidzic M, Gormley M, Goldfien G, Fisher S. Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion. 2011;51 Suppl 4:94S-105S pubmed 出版商
  26. Borowitz M, Craig F, DiGiuseppe J, Illingworth A, Rosse W, Sutherland D, et al. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom. 2010;78:211-30 pubmed 出版商
  27. Keysar S, Fox M. Kinetics of CHO A L mutant expression after treatment with gamma radiation, EMS, and asbestos. Cytometry A. 2009;75:412-9 pubmed 出版商
  28. Willcocks L, Lyons P, Clatworthy M, Robinson J, Yang W, Newland S, et al. Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med. 2008;205:1573-82 pubmed 出版商
  29. Williams M, Densmore J, Pawluczkowycz A, Beum P, Kennedy A, Lindorfer M, et al. Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia. J Immunol. 2006;177:7435-43 pubmed
  30. Zucchetto A, Sonego P, Degan M, Bomben R, Dal Bo M, Russo S, et al. Signature of B-CLL with different prognosis by Shrunken centroids of surface antigen expression profiling. J Cell Physiol. 2005;204:113-23 pubmed
  31. Thomason R, Papiez J, Lee R, Szczarkowski W. Identification of unsuspected PNH-type cells in flow cytometric immunophenotypic analysis of peripheral blood and bone marrow. Am J Clin Pathol. 2004;122:128-34 pubmed
  32. Suskind D, Muench M. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol. 2004;40:261-8 pubmed
  33. Fierro M, Savoia P, Quaglino P, Novelli M, Barberis M, Bernengo M. Systemic therapy with cyclophosphamide and anti-CD20 antibody (rituximab) in relapsed primary cutaneous B-cell lymphoma: a report of 7 cases. J Am Acad Dermatol. 2003;49:281-7 pubmed
  34. Holada K, Mondoro T, Muller J, Vostal J. Increased expression of phosphatidylinositol-specific phospholipase C resistant prion proteins on the surface of activated platelets. Br J Haematol. 1998;103:276-82 pubmed
  35. Solomon K, Rudd C, Finberg R. The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes. Proc Natl Acad Sci U S A. 1996;93:6053-8 pubmed
  36. Koski C, Estep A, Sawant Mane S, Shin M, Highbarger L, Hansch G. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins. J Neurochem. 1996;66:303-12 pubmed
  37. Tseng J, Hall S, Howard T, Ware R. Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria. Am J Hematol. 1995;50:244-53 pubmed
  38. Philbrick W, Palfree R, Maher S, Bridgett M, Sirlin S, Bothwell A. The CD59 antigen is a structural homologue of murine Ly-6 antigens but lacks interferon inducibility. Eur J Immunol. 1990;20:87-92 pubmed